Distribution Agreement with EnvoyAI
- 15 January 2019
Resonance Health is pleased to announce that it has entered into a Distribution Agreement with EnvoyAI for the distribution of the Company’s FerriSmart® product, which recently received FDA regulatory clearance.
FDA Clearance Granted for FerriSmart
- 03 December 2018
Resonance Health is please to announce that it has received 510(k) clearance from the US Food and Drug Administration for FerriSmart®, the Company's ground-breaking machine learning solution for the quantification of liver iron concentration.
TGA, CE Mark clearance for A.I. Solution FerriSmart
- 11 July 2018
Resonance Health is pleased to announce that FerriSmart®, its groundbreaking AI solution for the quantification of liver iron concentration (LIC), has now achieved TGA and CE Mark clearance, making it the only regulatory approved artificial intelligence tool for use in liver iron quantification.
Alliance Partner Agreement with Blackford Analysis
- 05 July 2018
Resonance Health is pleased to announce today that it has signed an Alliance Partner Agreement with Blackford Analysis.
Resonance Health News - June 2018
- 29 June 2018
Resonance Health is delighted to provide you with our latest quarterly newsletter where you can find an update on all our latest acitvities.
To read the newsletter please click here
Resonance announces Deal to distribute Diabetic Retinopathy AI tool
- 04 May 2018
Resonance Health is pleased to announce today that it has signed an agency agreement to distribute an Artificial Intelligence (AI) Diabetic Retinopathy (DR) grading tool. The contract is for a 2 year period, renewable based on performance and written agreement.